Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …
Appointment

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …
Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
Feature
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Appointment

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …
Appointment

Gilead collaborate with Merck for first-line triple negative breast cancer trial

October 29, 2021 Medical Communications

Gilead Sciences announced that it has entered into a clinical trial collaboration and supply agreement with MSD (known as Merck …
News

Fluvoxamine effective in reducing hospitalisation in COVID-19 patients

October 29, 2021 Medical Communications

A Brazilian study has assessed the effect of early treatment with fluvoxamine on the risk of emergency care and hospitalisation …
News

FDA approve Susvimo for wet age-related macular degeneration

October 29, 2021 Medical Communications

Genentech have announced that Susvimo, previously known as the port delivery system, is the fist wet age-related macular degeneration (AMD) …
News

XBiotech to launch novel therapy for stroke patients in US

October 29, 2021 Medical Communications

Clinical stage biopharmaceutical company, XBiotech, plans to test its new True Human™ antibody therapy for reducing brain injury after stroke, …
News

Companion test for lung cancer approved by FDA

October 22, 2021 Medical Communications

The US FDA has approved of the Roche VENTANA PD-L1 Assay as a companion diagnostic for Tecentriq® in non-small cell …
News

Servier Phase III colorectal cancer trial fails to meet primary endpoint

October 22, 2021 Medical Communications

Global independent pharmaceutical group, Servier, has announced that the primary objective (progression free survival) of the Phase III SOLSTICE trial …
News

CDC approves the mixing of COVID shots

October 22, 2021 Medical Communications

The US Centers for Disease Control and Prevention (CDC) has backed a plan to allow COVID-19 vaccine boosters for recipients …
News

Xtrava Health Receives Emergency Use Authorisation for COVID-19 Ag Test

October 22, 2021 Medical Communications

The US FDA has issued an Emergency Use Authorisation (EUA) for Xtrava’s SPERA™ COVID-19 Ag Test. The easy-to-use, rapid lateral …
News

First Indian anti-cancer drug launches in China

October 15, 2021 Medical Communications

The first Indian anti-cancer drug, Abiraterone Acetate API, has launched in China, by Dr Reddy’s Laboratories. This breakthrough was announced …
News
moderna_norwood_plant

FDA approves emergency booster dose of Moderna’s COVID-19 vaccine

October 15, 2021 Medical Communications

The FDA Advisory Committee has unanimously voted in support of emergency use for a booster dose of Moderna’s COVID-19 vaccine …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026